Kurs
+1,55%
Likviditet
1,20 MDKK
Kalender
| Est. tid* | ||
| 2027-02-02 | 08:00 | Bokslutskommuniké 2026 |
| 2026-10-20 | 07:00 | Kvartalsrapport 2026-Q3 |
| 2026-07-21 | 07:00 | Kvartalsrapport 2026-Q2 |
| 2026-04-28 | 07:00 | Kvartalsrapport 2026-Q1 |
| 2026-03-10 | N/A | Årsstämma |
| 2026-02-03 | 08:00 | Bokslutskommuniké 2025 |
| 2025-10-21 | - | Kvartalsrapport 2025-Q3 |
| 2025-07-22 | - | Kvartalsrapport 2025-Q2 |
| 2025-04-29 | - | Kvartalsrapport 2025-Q1 |
| 2025-03-13 | - | X-dag ordinarie utdelning EMBLA 0.00 DKK |
| 2025-03-12 | - | Årsstämma |
| 2025-02-05 | - | Bokslutskommuniké 2024 |
| 2024-10-22 | - | Kvartalsrapport 2024-Q3 |
| 2024-07-23 | - | Kvartalsrapport 2024-Q2 |
| 2024-04-23 | - | Kvartalsrapport 2024-Q1 |
| 2024-03-13 | - | Årsstämma |
| 2024-03-13 | - | X-dag ordinarie utdelning EMBLA 0.00 DKK |
| 2024-03-12 | - | Årsstämma |
| 2024-01-30 | - | Bokslutskommuniké 2023 |
| 2023-10-24 | - | Kvartalsrapport 2023-Q3 |
| 2023-07-25 | - | Kvartalsrapport 2023-Q2 |
| 2023-04-25 | - | Kvartalsrapport 2023-Q1 |
| 2023-03-13 | - | X-dag ordinarie utdelning EMBLA 0.00 DKK |
| 2023-03-10 | - | Årsstämma |
| 2023-01-31 | - | Bokslutskommuniké 2022 |
| 2022-10-25 | - | Kvartalsrapport 2022-Q3 |
| 2022-07-21 | - | Kvartalsrapport 2022-Q2 |
| 2022-04-26 | - | Kvartalsrapport 2022-Q1 |
| 2022-03-09 | - | X-dag ordinarie utdelning EMBLA 0.00 DKK |
| 2022-03-08 | - | Årsstämma |
| 2022-02-01 | - | Bokslutskommuniké 2021 |
| 2021-10-26 | - | Kvartalsrapport 2021-Q3 |
| 2021-07-22 | - | Kvartalsrapport 2021-Q2 |
| 2021-04-27 | - | Kvartalsrapport 2021-Q1 |
| 2021-03-09 | - | X-dag ordinarie utdelning EMBLA 0.00 DKK |
| 2021-03-08 | - | Årsstämma |
| 2021-02-02 | - | Bokslutskommuniké 2020 |
| 2020-10-27 | - | Kvartalsrapport 2020-Q3 |
| 2020-07-23 | - | Kvartalsrapport 2020-Q2 |
| 2020-04-30 | - | Kvartalsrapport 2020-Q1 |
| 2020-03-13 | - | X-dag ordinarie utdelning EMBLA 0.15 DKK |
| 2020-03-12 | - | Årsstämma |
| 2020-02-04 | - | Bokslutskommuniké 2019 |
| 2019-10-22 | - | Kvartalsrapport 2019-Q3 |
| 2019-07-25 | - | Kvartalsrapport 2019-Q2 |
| 2019-04-30 | - | Kvartalsrapport 2019-Q1 |
| 2019-03-08 | - | X-dag ordinarie utdelning EMBLA 0.14 DKK |
| 2019-03-07 | - | Årsstämma |
| 2019-02-05 | - | Bokslutskommuniké 2018 |
| 2018-10-24 | - | Kvartalsrapport 2018-Q3 |
| 2018-07-25 | - | Kvartalsrapport 2018-Q2 |
| 2018-04-25 | - | Kvartalsrapport 2018-Q1 |
| 2018-03-09 | - | X-dag ordinarie utdelning EMBLA 0.13 DKK |
| 2018-03-08 | - | Årsstämma |
| 2018-02-05 | - | Bokslutskommuniké 2017 |
| 2017-10-24 | - | Kvartalsrapport 2017-Q3 |
| 2017-07-25 | - | Kvartalsrapport 2017-Q2 |
| 2017-04-27 | - | Kvartalsrapport 2017-Q1 |
| 2017-03-10 | - | X-dag ordinarie utdelning EMBLA 0.12 DKK |
| 2016-03-11 | - | X-dag ordinarie utdelning EMBLA 0.12 DKK |
| 2016-03-10 | - | Årsstämma |
| 2016-02-02 | - | Bokslutskommuniké 2015 |
| 2015-10-22 | - | Kvartalsrapport 2015-Q3 |
| 2015-07-23 | - | Kvartalsrapport 2015-Q2 |
| 2015-04-29 | - | Kvartalsrapport 2015-Q1 |
| 2015-03-12 | - | Årsstämma |
| 2015-02-05 | - | Bokslutskommuniké 2014 |
| 2014-10-24 | - | Analytiker möte 2014 |
| 2014-10-23 | - | Kvartalsrapport 2014-Q3 |
| 2014-07-25 | - | Analytiker möte 2014 |
| 2014-07-24 | - | Kvartalsrapport 2014-Q2 |
| 2014-04-30 | - | Analytiker möte 2014 |
| 2014-04-29 | - | Kvartalsrapport 2014-Q1 |
| 2014-03-14 | - | Årsstämma |
| 2014-02-05 | - | Bokslutskommuniké 2013 |
| 2013-10-24 | - | Analytiker möte 2013 |
| 2013-10-23 | - | Kvartalsrapport 2013-Q3 |
| 2013-07-24 | - | Kvartalsrapport 2013-Q2 |
| 2013-04-24 | - | Kvartalsrapport 2013-Q1 |
| 2013-03-15 | - | Årsstämma |
| 2013-02-06 | - | Bokslutskommuniké 2012 |
| 2012-11-28 | - | Kapitalmarknadsdag 2012 |
| 2012-11-27 | - | Kapitalmarknadsdag 2012 |
| 2012-10-24 | - | Analytiker möte 2012 |
| 2012-10-23 | - | Kvartalsrapport 2012-Q3 |
| 2012-07-25 | - | Kvartalsrapport 2012-Q2 |
| 2012-04-24 | - | Kvartalsrapport 2012-Q1 |
| 2012-03-16 | - | Årsstämma |
| 2012-02-08 | - | Bokslutskommuniké 2011 |
| 2011-10-27 | - | Kvartalsrapport 2011-Q3 |
| 2011-07-28 | - | Kvartalsrapport 2011-Q2 |
| 2011-03-04 | - | Årsstämma |
Beskrivning
| Land | Island |
|---|---|
| Lista | Large Cap Copenhagen |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Intresserad av bolagets nyckeltal?
Analysera bolaget i Börsdata!
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
Reykjavik, Iceland/Copenhagen, Denmark, 9 January 2026. Embla Medical (Nasdaq Copenhagen: EMBLA) will publish its Q4/FY 2025 Report on February 3, 2026, at 7:00 CET. A conference call will be hosted on the same day at 9:00 CET / 7:00 GMT / 3:00am EST.
The event will be hosted by Sveinn Solvason, President and CEO, and G. Arna Sveinsdottir, CFO. The call will include a review of the quarterly results and will be held in English.
Slides used in the presentation will be made available on the company website at the following link: https://www.emblamedical.com/investors
To participate in the telephone conference, please use the dial-in details provided below:
DK: +45 78 76 84 90
SE: +46 31-311 50 03
UK: +44 20 3769 6819
US: +1 646 787 0157
Participant access code: 274982
The webcast will be available through following link: Embla Medical Q4 2025 webcast
Financial calendar and events 2026
January 8, 2026 SEB Nordic Seminar, Copenhagen
February 3, 2026 Interim Report Q4 2025 & 2025 Annual Report
February 3, 2026 Q4/FY 2025 HCA Capital virtual presentation and Q&A
February 3, 2026 Q4/FY 2025 Investor Road Show, Copenhagen (Nordea)
February 4, 2026 Q4/FY 2025 Investor Road Show, Stockholm (Nordea) and Paris (ABG)
February 5, 2026 Q4/FY 2025 Investor Road Show, London (Berenberg) and Zürich (Berenberg)
February 6, 2026 Q4/FY 2025 Investor Road Show, Reykjavik (Embla HQ)
February 10, 2026 Aktiespararna Company Event, Falkenberg Sweden
March 10, 2026 2026 Annual General Meeting
March 11, 2026 DNB Carnegie Healthcare Conference, Stockholm
March 26 2026 DNB BackBay Nordic-American Healthcare Conference, New York City
April 28, 2026 Interim Report Q1 2026
July 21, 2026 Interim Report Q2 2026
October 20, 2026 Interim Report Q3 2026
February 2, 2027 Interim Report Q4 2026/Annual Report
If you wish to receive Embla Medical press releases by e-mail, please register here
For further information please contact
Klaus Sindahl
Head of Investor Relations
M: +45 5363 0134
About Embla Medical
Embla Medical (Nasdaq Copenhagen: EMBLA) is a leading global provider of innovative mobility solutions that help people live a Life Without Limitations®. Home to several leading brands, Embla Medical is dedicated to improving people`s mobility by providing prosthetics, neuro orthotics, bracing and patient care through global network of Oorthotic and& Pprosthetic (O&P) patient care clinics.facilities. Embla Medical is committed to sustainable business practices and is renowned for positively impacting people`s health and well-being. www.emblamedical.com